Table 1.
Pre-Treatment |
Post-Treatment |
3MFU |
6MFU |
||||||
---|---|---|---|---|---|---|---|---|---|
M | (SD) | M | (SD) | M | (SD) | M | (SD) | ||
SAD composite | WL | 0.88 | (0.84) | −0.09 | (0.89) | – | – | – | – |
VRE | 1.31 | (0.61) | −0.52 | (0.60) | −0.45 | (0.46) | −0.49 | (0.77) | |
SPDQ | WL | 16.99 | (4.42) | 12.53 | (4.92) | – | – | – | – |
VRE | 19.12 | (3.50) | 9.52 | (3.51) | 10.10 | (2.63) | 10.26 | (4.30) | |
SIAS | WL | 46.45 | (14.54) | 29.80 | (13.28) | – | – | – | – |
VRE | 53.48 | (9.53) | 25.29 | (9.50) | 25.82 | (8.68) | 23.95 | (12.00) | |
MASI | WL | 70.46 | (16.27) | 47.89 | (22.48) | – | – | – | – |
VRE | 74.87 | (15.80) | 38.35 | (14.72) | 42.21 | (12.16) | 37.80 | (18.08) | |
PSWQ | WL | 60.19 | (7.81) | 47.09 | (7.71) | – | – | – | – |
VRE | 67.60 | (6.92) | 46.42 | (8.73) | 49.01 | (10.06) | 43.01 | (15.12) | |
PHQ-9 | WL | 11.20 | (6.01) | 7.94 | (3.60) | – | – | – | – |
VRE | 13.20 | (5.80) | 6.46 | (3.11) | 7.46 | (1.57) | 6.22 | (4.07) |
Note. FU = follow-up; MASI = job interview anxiety scale; PHQ-9 = patient health questionnaire–9-item; PSWQ = Penn State worry questionnaire; SAD composite = averaged standardized score of the social interaction anxiety scale and social phobia diagnostic questionnaire; VRE = virtual reality exposure therapy; WL = waitlist control condition.